We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

BioPerfectus Technologies

Bioperfectus Technologies Co., Ltd. is one of the leading molecular diagnostic solution providers in the global in-vi... read more Featured Products: More products

Download Mobile App





BioPerfectus Presents Total PCR Solution at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 08 Feb 2023

Jiangsu Bioperfectus Technologies Co. More...

, Ltd. (Shanghai, China) is presenting its Total PCR Solution at Medlab Middle East 2023 that can improve operational and cost efficiency, optimize workflow, and increase performance at every opportunity.

Bioperfectus Total PCR Solution offers holistic products of extraction systems, extraction reagents, real-time PCR systems, and RT-PCR reagents. These products could cover PCR detection workflow and assure the users with reassuring results by validated performance. At Medlab Middle East 2023, Bioperfectus is highlighting the STC-96A Plus Real-Time PCR system that is a more-than-ever flexible, efficient and reliable breakthrough in the real-time PCR analysis of gene expression and genetic variation. Bioperfectus is also highlighting the SAW-96 automated nucleic acid extraction workstation, an in-vitro diagnostic medical device that integrates cutting-edge mechanical, electronic, and software technologies. In addition, Bioperfectus is showcasing the SSNP-2000B nucleic acid extraction system, which integrates new technologies such as machine, electricity and computer software to enable automatic nucleic acid extraction of 32 samples maximum in one time.

Among its other nucleic acid extraction solutions, Bioperfectus is highlighting the SMPE-960 nucleic acid extraction system which integrates cutting-edge mechanical, electronic and software technologies to enable automated extraction of nucleic acids from samples. Featuring a modular structure, the SMPE-960 can extract nucleic acids from 1-96 samples in three independently operating modules at the same time. Bioperfectus is also providing a glimpse of its new products to be launched soon, including the SSNP-A6 nucleic acid extraction system that can extract nucleic acids from 96 samples simultaneously to meet the requirement for high throughput laboratories, alongside the SSP-1196 automatic sample preparing system that enables automated capping, scanning of barcode, transfer of sample liquid to the extraction plate, decapping and ready to extraction.

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd.


Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
Automated Urinalysis Solution
UN-9000
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The SimpleScreen CRC platform uses multiomics, AI, and machine learning to analyze blood-based signals and detect cancer-associated patterns (Photo courtesy of Freenome)

Blood Test Achieves Improved Detection of Advanced Precancerous Colorectal Lesions

Colorectal cancer is the second-leading cause of cancer-related death in the United States, yet screening uptake remains suboptimal. More than 50 million eligible adults are not up to date with recommended... Read more

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.